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Abstract: Exposure to β-N-methylamino-L-alanine (BMAA) might be linked to the incidence of
amyotrophic lateral sclerosis, Alzheimer’s disease and Parkinson’s disease. Analytical chemistry
plays a crucial role in determining human BMAA exposure and the associated health risk, but the
performance of various analytical methods currently employed is rarely compared. A CYANOCOST
initiated workshop was organized aimed at training scientists in BMAA analysis, creating mutual
understanding and paving the way towards interlaboratory comparison exercises. During
this workshop, we tested different methods (extraction followed by derivatization and liquid
chromatography coupled to tandem mass spectrometry (LC-MS/MS) analysis, or directly followed
by LC-MS/MS analysis) for trueness and intermediate precision. We adapted three workup methods
for the underivatized analysis of animal, brain and cyanobacterial samples. Based on recovery of
the internal standard D3BMAA, the underivatized methods were accurate (mean recovery 80%) and
precise (mean relative standard deviation 10%), except for the cyanobacterium Leptolyngbya. However,
total BMAA concentrations in the positive controls (cycad seeds) showed higher variation (relative
standard deviation 21%–32%), implying that D3BMAA was not a good indicator for the release of
BMAA from bound forms. Significant losses occurred during workup for the derivatized method,
resulting in low recovery (<10%). Most BMAA was found in a trichloroacetic acid soluble, bound
form and we recommend including this fraction during analysis.
Keywords: β-N-methylamino-L-alanine (BMAA); 6-aminoquinolyl-N-hydroxysuccinimidyl
carbamate (AQC); α,γ-diaminobutyric acid (DAB); cycad; Daphnia magna; hydrophilic interaction
liquid chromatography (HILIC); Internal standard; Liquid chromatography-tandem mass
spectrometry (LC-MS/MS); N-(2-aminoethyl) glycine (AEG); phytoplankton; seafood
1. Introduction
The neurotoxin β-N-methylamino-L-alanine (BMAA) is suspected to play a role in the progressive
neurological diseases amyotrophic lateral sclerosis, Alzheimer’s disease and Parkinson’s disease [1–4].
Potential routes of human exposure to BMAA include contact with cyanobacteria infested surface
waters and ingestion of BMAA containing food, such as fish and shellfish [5]. However, extensive
research is needed to determine the precise role of BMAA in the etiology of these diseases along with
characterization of pathways of human exposure.
To assess the health risk associated with BMAA, routes of human exposure are being quantified.
BMAA can be present in natural phytoplankton (e.g., [6–8]) and can be taken up by aquatic organisms
such as zooplankton [9–11], bivalves [12] and macrophytes [13]. Indeed, BMAA has been found in
natural zooplankton and shellfish samples [7,14,15]. Moreover, it has been detected in other organisms
from higher levels of the aquatic food web [7], including fish intended for human consumption [7,16].
Reported BMAA concentrations in phytoplankton and higher aquatic organisms vary widely, and a
substantial part of this variation can be attributed to the use of nonselective analytical methods [17].
BMAA concentrations in aquatic organisms seem to lie within the ng/g dry weight (DW) to µg/g DW
range in studies using well described analytical techniques supported by performance data [5].
Analytical procedures (method selectivity and sensitivity, fraction analyzed, quality control) play a
critical role in assessing the putative link between BMAA and the abovementioned neurodegenerative
diseases [18,19], as well as in the quantification of human exposure pathways [5]. Over the past years,
many different analytical methods have been developed and at present, methods using tandem
mass spectrometry (MS/MS) detection following proper sample processing are considered most
suitable [5,17,20]. LC-MS/MS is currently the most frequently applied technique for BMAA analysis
and within this technique, diverse sample processing and separation methods are used [5].
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In natural samples, BMAA can be present as a free molecule or in bound forms. “Free BMAA”
is the fraction obtained by extraction with polar solvents such as 0.1 M trichloroacetic acid (TCA)
(Figure 1). Bound forms of BMAA can either stay in solution (“soluble bound BMAA”) or precipitate
during extraction (“precipitated bound BMAA”) and BMAA can be released from both bound forms
by acid hydrolysis (Figure 1). The total BMAA content of a sample is usually obtained by hydrolysis
of the total sample (Figure 1). The precursor(s) of soluble bound BMAA have not been elucidated
yet, but recently it was suggested that in mussels, soluble bound BMAA might not be bound to a
peptide or protein [21]. The precursor(s) of the precipitated bound BMAA fraction are also unknown.
This fraction is commonly referred to as “protein associated” or “protein bound” [22,23], but the
association of BMAA with proteins in natural samples still needs to be elucidated. In vitro, BMAA can
be incorporated into proteins and can be associated to proteins through non-covalent bonding [24,25],
but in vivo experiments with bacteria do not show protein incorporation [26].
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Figure 1. Terminology used in this manuscript for the different β-N-methylamino-L-alanine (BMAA)
fractions. Free and soluble bound BMAA are found in the trichloroacetic acid (TCA) extract.
Precipitated bound B AA is found in the pellet created during extraction. Total B AA is the su of
all fractions.
Only few studies look at soluble bound BMAA in an isolated fraction (e.g., [15,21,27,28]). In studies
where total BMAA (i.e., hydrolysis of the total sample) is (also) determined, ignoring soluble bound
BMAA does not lead to an underestimation of the total BMAA concentration. However, when only
free and precipitated bound BMAA are analyzed (e.g., [6,22,29] and more recently [11,12,30]) total
BMAA concentrations might be underestimated, and the fate of BMAA in experimental systems might
be difficult to assess. As an example, in a recent study on BMAA metabolism in the macrophyte
Ceratophyllum demersum, in which only free and precipitated bound BMAA were analyzed, detectable
BMAA concentrations in the exposed plants dropped during depuration, while no BMAA was found
in the depuration medium and BMAA catabolism did not seem to have occurred. This lead the authors
to conclude that BMAA was likely covalently bound in a form undetectable by the analytical methods
employed [30].
After extraction, BMAA can be analyzed by LC-MS/MS without derivatization. As BMAA is
a small, polar molecule, hydrophilic interaction liquid chromatography (HILIC) is in these cases
predominantly used for separation (e.g., [6,15,31–33]). BMAA can also be derivatized after extraction
to obtain a larger, more hydrophobic molecule which is easily separated by reversed phase liquid
chromatography. Commonly used derivatization agents are 6-aminoquinolyl-N-hydroxysuccinimidyl
carbamate (AQC, e.g., [8,34,35]), propyl chloroformate (e.g., [26,36]) and dansyl chloride [14,37].
As outlined above, analytical chemistry plays an essential role in BMAA risk assessment, but to
date, method harmonization and inter-laboratory comparison of methods have not yet been performed.
During a workshop organized in Wageningen University under the auspices of the CYANOCOST
network (COST Action ES 1105), analysts from different labs were trained in BMAA analysis and BMAA
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methods were discussed. By doing so, we aimed to create mutual understanding and to pave the
way towards an inter-laboratory comparison exercise and ultimately towards method harmonization.
During this workshop, samples from four relevant matrices (cycad, animal, brain and cyanobacteria)
were extracted with at least two different methods (one followed by derivatization before LC-MS/MS
analysis and one directly followed by LC-MS/MS analysis), and each workup was performed by
two pairs of analysts. All samples were analyzed by LC-MS/MS by one operator. The analysts were
experienced in cyanotoxin analysis, were provided with detailed protocols and instructions and were
intensively supported by the three trainers who had developed the methods used.
2. Experimental Design
Three different sample types, animal samples (seafood and BMAA exposed Daphnia magna), brain
tissue (unspiked and spiked with BMAA before workup) and cyanobacterial samples (Leptolyngbya
PCC 73110 and an Anabaena dominated field sample), were prepared for underivatized and AQC
derivatized LC-MS/MS analysis (detailed Materials and Methods are described in Supplementary
Material S1 (underivatized protocols) and Supplementary Material S2 (derivatized protocol)).
We selected sample preparation methods that were published, validated and developed by the trainers
of the workshop (see [17] for underivatized analysis of animal and cyanobacterial samples, [38] for
underivatized analysis in brain and [16] for AQC derivatized analysis of all sample types). Where
needed, the extraction methods were adapted to the available equipment.
The sample preparations were performed by the workshop participants. An open call was
distributed through the CYANOCOST network and the selection of participants was carried out
jointly by CYANOCOST Working Group 3: “Cyanotoxin analysis” leaders and by the local organizers.
Selection was largely based on the applicants’ experience with cyanotoxin analysis, and especially
with LC-MS/MS analysis. During the workshop, the following measures were taken to minimize
any variation caused by lack of training: Before starting the practical work, all participants attended
lectures on the chemical properties of BMAA and on methods of BMAA analysis. All participants
were given detailed documented protocols for the different extraction methods and were trained in the
techniques and instrumentation used. Constant technical support was provided by three trainers who
developed the sample preparation (Ilag/Zguna for protocol D, Combes for protocol B and Faassen
for protocol A and C) and by laboratory technicians who had experience with the methods used.
All LC-MS/MS analyses were performed on an Agilent 1260 LC coupled to an Agilent 6460 triple
quadrupole mass spectrometer by one operator.
The samples that were prepared for underivatized LC-MS/MS analysis were extracted with
0.1 M TCA at ambient temperature to obtain free BMAA. Total BMAA was obtained by 6 M HCl
hydrolysis of the total sample. For the animal samples, total soluble BMAA was also determined by
hydrolyzing the dried 0.1 M TCA extract with 6 M HCl. This fraction was not determined for the
other two sample types because we did not have brain and cyanobacterial samples with relatively
high BMAA concentrations. The workup for the brain samples included an additional cleanup step by
Oasis MCX solid phase extraction (SPE, Figure 2).
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Figure 2. Sample preparation schemes for the analysis of underivatized BMAA in three different
matrices: animal tissue other than brain (protocol A), brain tissue (protocol B) and cyanobacterial
samples (protocol C). The workup for total BMAA is the same in method A and C. Workup for free
BMAA in these protocols only differs in the point at which D3BMAA was added.
In all protocols, D3BMAA was added as internal standard, and blanks (workup without matrix,
negative controls) and cycad seed sarcotesta (positive controls) were included. All samples and controls
were prepared i triplicate by two pairs of analyst, resulting in six workups per sample (see Table S1.1
in Supplementary Mat rial S1).
We intended to use the derivatized protocol for total BMAA determination in all sample types.
However, in agreement with a recent method evaluation in an independent laboratory [39], we obtained
such a poor recovery with the derivatized protocol (Protocol D, recovery < 10%) that we did not use it
for BMAA quantification. From this point on, the manuscript therefore focuses on the underivatized
protocols, and he results and discussion for the derivatized protocol can be found in Supplementary
Material S2.
3. Results and Di cussion
3.1. Trueness and Pr cision
Trueness of protocols A, B and C, expressed as mean recovery of D3BMAA added before workup,
were not all within the acceptable range of 70%–120% [40] (Table 1). Some fractions of the control
samples gave a sligh ly lower recovery (between 59% and 69%) a d D3BMAA recovery in Leptolyngbya
was very low (7%–21%). Better recoveries (88%–100% for the free fraction and 56%–75 for the
total samples) had previously been obtained for cyanobacterial labstrains extracted with the same
protocol [17] and it is unclear what has caused the low recovery in this Leptolyngbya strain. In contrast
to Leptolyngbya, D3BMAA recovery from the free fraction in Daphnia (141%) was too high. When the
workup was repeated, D3BMAA recovery was well within the acceptable range (103%, SD 7.4, n = 3).
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Table 1. Trueness (mean D3BMAA recovery (%)) and intermediate precision (relative standard
deviation of D3BMAA recovery, n = 6, results of both pairs combined), for samples prepared for
underivatized analysis. Trueness outside the acceptable range is indicated with blue (<70%) and red
(>120%). Precision exceeding the acceptable value (20) is indicated with red [40].
Protocol Animal (A) Brain (B) Cyanobacteria (C)
Fraction Free T.S. 1 Total Free Total Free Total
Blank 85 (2.6) 65 (4.9) 81 (13.7) 78 (4.8) 72 (8.4) 100 (7.8) 59 (6.3)
Cycad 93 (7.8) 64 (11.4) 86 (2.1) * 69 (7.5) 73 (2.5) 103 (8.5) 65 (4.3)
Seafood 96 (6.6) 78 (7.9) 108 (6.7) - - - -
Daphnia magna 141 (2.5) 75 (1.0) 110 (8.0) - - - -
Brain unspiked - - - 77 (11.1) 84 (15.7) - -
Brain spiked - - - 80 (6.0) 82 (9.0) - -
Anabaena - - - - - 103 (7.4) 78 (2.3)
Leptolyngbya - - - - - 21 p61.0q 7 p41.5q
1 Total Soluble, * n = 5.
Intermediate precision (within-laboratory reproducibility, expressed as relative standard deviation
of D3BMAA recovery) was below 10% for most, and below 20% for all samples except for Leptolyngbya
(Table 1). The workup in protocol A and C was essentially the same for free BMAA and exactly
the same for total BMAA, but the extractions were performed on different days. When the results
of protocols A and C were combined, the precision was still within the acceptable range: 9.8% for
D3BMAA recovery in the free fraction in blanks, 9.4% in the free fraction of cycads, 19.5% in the total
fraction in blanks (all n = 12) and 15.1% in the total fraction of cycads (n = 11).
In Table 1, trueness and intermediate precision were based on the recovery of D3BMAA that
was added as a free compound, as no “bound” D3BMAA or BMAA is available. When intermediate
precision is expressed as the relative standard deviation of the amount of BMAA found in the positive
control (cycad seed), which does contain bound forms of BMAA, it shows that in all three protocols,
intermediate precision for total BMAA is greater than 20% and that correction for D3BMAA recovery
does not increase precision (Table 2). For total BMAA determination, D3BMAA recovery and the
BMAA concentrations uncorrected for D3BMAA recovery were not correlated (Pearson product
moment correlation, p = 0.15, n = 17, see Supplementary Figure S3), in contrast to the free fraction,
where this correlation did exist (correlation coefficient 0.88, p < 0.001, n = 18, see Supplementary
Figure S3). Assuming that the stability of (free) BMAA and D3BMAA is the same, this implies that
during workup for total BMAA (and possibly also for soluble bound BMAA), small procedural
variations have affected the release or formation of BMAA, but not, or to a lesser extent, its stability
or signal suppression. This also suggests, that although each method seemed precise and accurate
based on D3BMAA recovery, correction for D3BMAA recovery only results in accurate quantification
of free BMAA and not in accurate quantification of bound forms. (Free) D3BMAA added before sample
procession does therefore seem to be a good indicator for losses during extraction and changes in
MS/MS signal due to matrix effects, but does not seem to accurately reflect the release or formation of
bound BMAA in natural samples.
Table 2. Intermediate precision expressed as relative standard deviation of the BMAA concentration
(µg/g DW) determined in cycad seed by underivatized analysis, data with and without correction for
D3BMAA recovery are shown (n = 6, results of both pairs combined). Results exceeding the acceptable
value (20, [40]) are indicated with red.
Protocol Animal (A) Brain (B) Cyanobacteria (C)
Fraction Free T. S. 1 Total Free Total Free Total
uncorrected for D3BMAA 10.3 8.4 22.9 * 13.5 31.4 18.5 20.5
corrected for D3BMAA 10.4 13.6 23.9 * 9.2 31.6 11.6 20.9
1 Total Soluble, * n = 5.
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3.2. BMAA in Blanks and Cycad Samples
No BMAA was detected in any of the blanks (negative controls). BMAA was detected in the cycad
seed (positive controls), free BMAA concentrations averaged 8.8 µg/g DW (SD 1.8, n = 18), which is
similar to the value previously determined in the same sample (10.7 µg/g DW, SD 2.9, n = 3 [17]).
BMAA was found in the hydrolyzed 0.1 M TCA extract (“total soluble BMAA” in Figure 3),
and total soluble BMAA exceeded the total BMAA concentration (t-test total soluble vs. total BMAA,
t21 = 3.071, p = 0.006, n = 23, Figure 3). Although the average total BMAA concentration in the
cycad seed as determined by all three protocols (75.2 µg/g DW, SD 33.1, n = 17) was consistent with
previously reported values for this sample (75.0 µg/g DW, SD 10.8, n = 3, [17]), these values differed
substantially between the protocols used in this study (Figure 3). This implies that the release of
BMAA from precursor bound forms, for which the addition of free D3BMAA as an internal standard
does not correct, is sensitive to slight variations in the workup procedure. In our study, hydrolysis
was performed overnight and incubation times were not strictly controlled or registered. Although
different hydrolysis procedures are currently applied by different labs [20], the effects of variations in
hydrolysis conditions have not been systematically evaluated yet. Given the variation observed in the
total BMAA determinations our study, this might be worth looking into. This work should be carried
out with samples containing bound forms of BMAA, preferably matrix matched certified reference
materials. Such materials are not available yet, but the recent finding of BMAA in commercially
available mussel material [41] is promising. Until certified reference materials are available, samples
that contain a relatively high concentration of bound BMAA, such as cycad seeds, can be used during
method development and comparison.
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Figure 3. BMAA concentrations in cycad seeds as determined by protocols A to C, results for both
pairs are combined. Error bars represent standard deviations, n = 6, except for total BMAA determined
by protocol A, where n = 5. “Total soluble BMAA” refers to the TCA soluble fraction, including
free BMAA.
3.3. BMAA in Brain Tissue
No BMAA was detected in the unspiked brain samples. An additional set of brain samples was
therefore spiked with BMAA before sample preparation. After TCA extraction, a BMAA concentration
of 3.0 µg/g DW (SD 0.1, n = 6) was determined, which was exactly the spiked concentration. The
BMAA concentration determined after hydrolysis of the total sample was 39.9 µg/g DW (SD 3.1, n = 6),
which is very close to the spiked concentration of 40 µg/g DW. These findings support our assumption
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(see Section 3.1) that BMAA and D3BMAA added before workup (i.e., the free compounds) behave
similar in terms of stability and signal suppression, both during 0.1 N TCA extraction and during 6 M
HCl hydrolysis.
3.4. BMAA in Animal and Cyanobacterial Samples
No BMAA was detected in any of the cyanobacterial samples. The Leptolyngbya strain used in this
study had been shown to contain BMAA at concentrations below 1 µg/g DW with AQC derivatized
LC-MS/MS methods [35,39], but no BMAA was detected in the same strain by underivatized
LC-MS/MS analysis ([15], LOD 0.225 µg/g DW). We did not detect BMAA in this strain, but this might
be attributed to the high LOD for this sample (estimated at 1 µg/g DW for free BMAA and 20 µg/g
DW for total BMAA, as opposed to 0.2 µg/g DW for free BMAA and 2.5 µg/g DW for total BMAA in
Anabaena field samples), which was caused by low recovery in Leptolyngbya.
In seafood samples, free BMAA was detected in two replicates, of which one was quantifiable at a
concentration of 0.3 µg/g DW. Highest BMAA concentrations were again found in the hydrolyzed
TCA extract (t-test total soluble vs. total BMAA, t10 = 2.330, p = 0.042, n = 12, Figure 4). The variation
within each fraction was considerable: relative SD of 21.8 for soluble bound BMAA and 58.2 for
total BMAA, where the relative SD of D3BMAA recovery was below 8% for both fractions (Table 1).
It is most likely that this variation is caused by small variations during workup (as discussed in
Sections 3.1 and 3.2) and possibly by sample heterogeneity, for both of which the addition of an
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Figure 4. BMAA concentrations in seafood samples as determined by protocol A, results for both pairs
are combined. Error bars represent standard deviations, n = 1 for free BMAA and n = 6 for each of the
other two fractions. “Total soluble” refers to the TCA soluble fraction, including free BMAA.
All Daph ia samples contained quantifiable amounts of free and total soluble BMAA (Figure 5).
Total soluble BMAA concentrations eq aled total BMAA concentrations (with outlier included:
Mann–Whitney rank sum test, U = 15, p = 0.699, n = 12; without outlier: t-test total soluble vs.
total BMAA, t9 = 0.768, p = 0.462, n = 11, Figure 5). The variation observed in the total BMAA results
may be due to sample heterogeneity along with differences in actual sample size (tissue weight) due to
incomplete drying of the animals. Unexposed Daphnia and their food source Scenedesmus obliquus did
not contain detectable amounts of BMAA [9,17].
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Figure 5. BMAA concentrations in BMAA exposed Daphnia as determined by protocol A, results for
both pairs are combined. Error bars represent standard deviations, n = 6, except for total BMAA, where
n = 5 and the sixth data point is presented as outlier. “Total soluble” refers to the TCA soluble fraction,
including free BMAA.
3.5. BMAA Fractions
Free BMAA was found in all cycad and Daphnia samples, and in two of the six seafood replicates.
Although free BMAA can slowly be released from bound forms during extraction with dilute acid at
low temperatures [21], we do not expect that this process has substantially added to the free BMAA
concentration we fou d as our handling times during TCA extraction wer short (less than one hour).
In the BMAA positive samples we analyzed, total soluble BMAA concentrations (free and soluble
bound BMAA, represented by the green bars in Figures 3–5) were relatively close to the total BMAA
concentrations (blue bars in same figures). The tested samples are therefore not expected to contain a
high percentage f precipitated bound BMAA. Ho ver, a direct com arative analysis of free, soluble
bound and precipitated bound BMAA is needed to definitively answer this question.
The form in which soluble bound BMAA was present in the hydrolyzed extract is unclear, because
from our experiment we can only derive that it was TCA soluble and that it was bound to a precursor.
Whether it is the same low m lecular weight, non-protein/peptide precursor as f und in mussels [21]
is unknown. Further work is needed to identify the structure(s) of this precursor, and to optimize its
extraction, as milder methods than the 6 M HCl liquid hydrolysis used in this study have been shown
to release soluble bound BMAA in mussels [21].
We det cted soluble b nd BMAA in all three BMAA posi ive samples (cycad, seafood and
exposed Daphnia). Although a li ited number of studies have determined this fraction so far,
soluble bound BMAA seems to occur in a diversity of organisms: cycad seeds (this study and [27]),
periphyton [28], plankton [8,28], and bivalves [15,21,28]. It is therefore recommended to include
soluble bound BMAA in future studies, for instance by hydrolyzing the total sample (e.g., [14,16,17]),
or by releasing it from the dried extract [8,15,21,28]. When only free and precipitated bound BMAA
are determined, the soluble bound fraction can be overlooked, potentially resulting in a substantial
underestimation of the total sample’s BMAA content.
4. Conclusions and Outlook
The three LC-MS/MS based protocols we tested to analyze underivatized BMAA in animal tissue,
brain tissue and cyanobacterial samples were generally accurate and precise in terms of D3BMAA
recovery, as well as for free BMAA determination in the positive control (cycad seeds). However, total
BMAA determination in cycad seeds was less precise (intermediate precision ranging from 20% to
Mar. Drugs 2016, 14, 45 10 of 12
32%). We suspect that small variations during workup have influenced the liberation or formation
of BMAA from bound forms, for which the addition of free D3BMAA as internal standard could not
correct. Given the observed variation in total BMAA concentrations in cycad seeds, we recommend
optimization of the workup for soluble bound and total BMAA, which should be performed with
samples containing bound BMAA.
The majority of the BMAA detected in the positive samples (cycad seeds, seafood and Daphnia)
was present in a bound form in the TCA extract. This fraction was released by liquid phase acid
hydrolysis, but additional work is needed to identify the structure of its precursor(s) and to optimize
its extraction. When only free and precipitated bound BMAA are determined, this fraction will be
overlooked. Until its structure has been elucidated and extraction has been optimized, we recommend
to include soluble bound BMAA either by determining total BMAA or by hydrolyzing (part of) the
extract used for free BMAA analysis.
During the workshop, scientists from 12 different research groups were provided with the
knowledge and skills to develop appropriate BMAA methods in their own laboratories. Furthermore,
mutual understanding was created by an open discussion on the pros and cons of different analytical
techniques and by evaluation of the conflicting data in BMAA literature. This common starting point
will facilitate the performance of interlaboratory comparison exercises, which are needed to progress
BMAA research [5].
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Protocol A  A A B B C  C  D 
BMAA fraction  free  t.s. 1 total  free  total free  total  total
Blank (neg. control)  5,6  5,6  1,2  1,2  3,4  3,4  5,6  1,3 
Cycad seed (pos. control)  5,6  5,6  1,2  1,2  3,4  3,4  5,6  2,4 
Seafood  5,6  5,6  1,2  ‐  ‐  ‐  ‐  3,4 
Daphnia magna  5,6  5,6  1,2  ‐  ‐  ‐  ‐  3,4 
Brain unspiked  ‐  ‐  ‐  1,2  3,4  ‐  ‐  5,6 
Brain spiked  ‐  ‐  ‐  1,2  3,4  ‐  ‐  5,6 
Anabaena  ‐  ‐  ‐  ‐  ‐  3,4  5,6  1,2 






crabmeat  and  Asari  clam  (Venerupis  philippinarum),  kindly  provided  by  Stephanie  Christensen, 









approximately  two  weeks.  After  exposure,  animals  were  rinsed  with  water,  freeze  dried  and 




taken  from  a  stranded  male  harbour  porpoise  (Phocoena  phocoena,  33.3  kg,  134  cm),  found  in 
Callantsoog  (The Netherlands) on 16  June 2008. The animal was  still  relative  fresh  (DCC 2), had 
slightly lost weight (NCC 3) and had probably died of pneumonia. The corpse was kept at −20 °C 
until dissection and the whole brain was then stored at the same temperature. Before the start of the 
experiment,  the  brain  was  freeze  dried  and  homogenized  in  a  food  processor.  The  Anabaena 
dominated scum sample was collected from a Dutch lake in 2008 and was stored at −20 °C after freeze 
drying. The lab strain Leptolyngbya PCC 73110 was kindly provided by Birgitta Bergman, Stockholm 




The  protocol  used  for  extraction  of  animal  samples  followed  by  underivatized  LC‐MS/MS 







to  an  Eppendorf  tube with  a  0.2  μm  cellulose  acetate  filter  (Grace Davison Discovery  Science, 
Columbia, USA) and centrifuged for 5 min at 16000× g. TCA (600 μL) was then added to the pellet, 
and after vortexing, centrifugation and filtration as described above, both extracts were combined. 






































after weighing,  three  replicate brain  samples  for each pair were  spiked with 40 ng L‐BMAA. An 
aliquot (40 μL) of the 2 mg/L D3BMAA solution was added to all samples, and after drying, hydrolysis 
was performed as described  in Section S.1.3. After hydrolysis, dried samples were quantitatively 











Total  BMAA  determination was  the  same  as  described  for  the  animal  samples  (method A, 









linear decreases between  the steps. During  the first 4 and  last 6 minutes  the flow was directed  to 
waste. Nitrogen was used as drying, sheath and collision gas and source settings were: drying gas 










Compound  Precursor  F 1  Quant 2 CE 3 Qual 4 CE Ratio 5 Qual  CE  Ratio
  m/z  V  m/z  V  m/z  V  %  m/z  V  % 
D3BMAA  122.1  50  105.1  4  88.1  8  27  76.2  8  43 
BMAA  119.1  50  102.1  4  88.1  8  25  76.2  8  25 
DAB  119.1  50  101.1  4  74.2  4  ‐  ‐  ‐  ‐ 
AEG  119.1  50  102.1  4  ‐  ‐  ‐  ‐  ‐  ‐ 












Figure S1.1. Chromatograms  of  underivatized LC‐MS/MS  analysis  of  a  calibration  standard  (left 


























transferred  to  a new Eppendorf  tube. Water plus  0.2%  formic  acid  (500  μL) was  added  and  the 

























Compound  Precursor  F 1  Quant 2 CE 3 Qual 4 CE Ratio 5 Qual  CE  Ratio
  m/z  V  m/z  V  m/z  V  %  m/z  V  % 
D3BMAA  462  134  171  35  145  16  12  122  16  27 
BMAA  459  143  171  32  258  25  3  119  16  28 
DAB  459  134  171  32  315  12  ‐  ‐  ‐  ‐ 
AEG  459  134  171  32  214  35  ‐  ‐  ‐  ‐ 


















concentration step (step e  in Figure S2.1), no extra  losses occurred  (recovery 34%, SD 9.0, n=3).  In 
addition  to  losses during  SPE,  strong  signal  suppression  has  been  reported  for  this method  [7]. 









The D3BMAA recovery of the protocol used in our study was  low, but this  is not  inherent to 
AQC based LC‐MS/MS methods as  in our case, a substantial part of the D3BMAA got  lost during 
workup. If coupled to appropriate workup protocols, AQC based methods can give good recoveries, 
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